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Molecular methods are important tools in the diagnosis of bloodstream bacterial infections, in particular in patients treated with
antimicrobial therapy, due to their quick turn-around time. Here we describe a new broad-range real-time PCR targeting the 23S
rDNA gene and capable to detect as low as 10 plasmid copies per reaction of targeted bacterial 23S rDNA gene. Two commercially
available DNA extraction kits were evaluated to assess their efficiency for the extraction of plasma and whole blood samples spiked
with different amount of either Staphylococcus aureus or Escherichia coli, in order to find the optimal extraction method to be
used. Manual QIAmp extraction method with enzyme pre-treatment resulted the most sensitive for detection of bacterial load.
Sensitivity of this novel assay ranged between 10 and 103 CFU per PCR reaction for E. coli and S. aureus in human whole blood
samples depending on the extraction methods used. Analysis of plasma samples showed a 10- to 100-fold reduction of bacterial 23S
rDNA in comparison to the corresponding whole blood specimens, thus indicating that whole blood is the preferential sample type
to be used in this real-time PCR protocol. Our results thus show that the 23S rDNA gene represents an optimal target for bacteria
quantification in human whole blood.
1. Introduction
Blood culture (BC) is the most widely used method for
the diagnosis of bloodstream bacterial infections (BSIs) [1].
Major limitations of culture techniques are the intrinsic
poor cultivability (or noncultivability) of some bacteria and
the inhibitory effects of concurrent antibiotic therapy. In
addition, the turn-around time of BC ranges from 24 to 72
hours, which implies that results might become available too
late to be of clinical utility [2]. In recent years, molecular
methods have been proposed as additional diagnostic tools
for BSIs [2, 3]. Several studies reported the development
and clinical assessment of broad-range real-time PCR pro-
tocols, capable of rapid detection and identification of a
vast proportion of cultivable and uncultivable bacteria, from
different types of biological samples [4–12]. The majority of
the broad-range real-time PCRs use a single pair of universal
primers to identify bacteria through the amplification of
the 16S ribosomal DNA (16S 0072DNA), given the high
level of homology of this gene throughout the bacterial
species diversity [12]. The amplification of the 16S rDNA has
been described as a specific and sensitive tool to identify
and quantify different microorganisms depending on the
specific protocol used [7, 13–17]. A major pitfall of 16S-based
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panbacterial primers is their cross-reactivity with human
ribosomal RNA genes; to overcome the problem, Kommedal
and coworkers proposed a 16S rDNA-based dual-priming
protocol [18]. In addition to 16S rDNA, the gene coding for
the large subunit ribosomal RNA (23S rDNA) has also been
targeted for the development of PCR methods for bacterial
detection, but only a limited number of studies evaluated
the utility of 23S-based panbacterial primers [4, 19], and no
studies have so far exploited this target for BSI monitoring.
The aim of our study was to develop a novel 23S rDNA-
targeted real-time pan-bacterial PCR method, suitable for
the detection of a wide range of bacterial species, for the
monitoring of BSIs. In addition, since the amount of bacterial
DNA detected in blood from healthy subjects is reported to
be highly variable and profoundly influenced by the use of
whole blood or plasma [4, 7, 20], we tested the suitability of
different extraction procedures for the isolation of bacterial
DNA from blood-derived specimens.
2. Materials and Methods
2.1. Design of the 23S rDNA Universal Primers. Complete
23S rDNA sequences from 50 bacterial species, span-
ning the eubacterial diversity, were retrieved from the
NCBI database (http://www.ncbi.nlm.nih.gov/). Alignment
of the sequences was performed using the MUSCLE soft-
ware [21] and manually checked. 28S rDNA sequences
from Caenorhabditis elegans, Candida albicans, Drosophila
melanogaster, and Homo sapiens were also included in the
alignment, in order to evaluate the specificity for the bacterial
rDNA of the designed primers. Primers were manually
designed on the obtained alignment, and then evaluated
using mfold (http://mfold.rna.albany.edu/?q=mfold) and the
Operon oligo analysis tool (http://www.operon.com/tools/
oligo-analysis-tool.aspx). The sequences of the 23S rDNA-
targeted pan-bacterial primers are PAN23S-F, 5󸀠-TCGCTC-
AACGGATAAAAG-3󸀠 and PAN23S-R, 5󸀠-GATGAnCCG-
ACATCGAGGTGC-3󸀠; the amplified fragment size is 97
base pairs in Escherichia coli. The designed primers were
then compared to the nonredundant nucleotide eukaryotic
database using the Blast software (http://blast.ncbi.nlm.nih
.gov/Blast.cgi), to highlight possible unwanted matches.
2.2. 23S rDNA Real-Time PCR. PCR reactions were effected
in a final volume of 25𝜇L, containing 12.5 𝜇L of SYBR
Green PCR Master Mix Reagent (Biorad-Hercules, CA,
USA), 250 nM of each primer, and 5 𝜇L of the extracted
DNA solution. PCR was performed in an IQ5 thermocycler
(Biorad-Hercules, CA, USA) with an initial step of 5min at
95∘C, followed by 40 cycles of 15 s at 95∘C and 30 s at 58∘C.
After PCR amplification, the melting curve was established
by increasing the temperature from 55∘C to 95∘C.
2.3. Bacterial Isolates. A panel of 47 different bacterial iso-
lates, 20 Gram-positive, and 27 Gram-negative was included
in the study (Table 1). These strains were either obtained
from routine cultures, identified at the Unit of Clinical
Microbiology, St. OrsolaMalpighi Hospital, or obtained from
Table 1: Bacterial strains utilized in this study. The strains were
either obtained from the bacterial collection of the St. Orsola
Hospital (BACSO) or derived from routine workflow. In this last
case the procedure for identification are reported in the Qualty
Assurance files of the Laboratory.
Microorganisms species Origin of the isolate
Acinetobacter baumannii Urine
Acinetobacter lwoffii Urine
Alcaligenes xylosoxidans Urine
Bacteroides fragilis Cerebrospinal fluid
Campylobacter jejuni Feces
Citrobacter braakii Abdominal drainage
Citrobacter freundii Blood
Citrobacter koseri Urine
Corynebacterium jeikeium Blood
Corynebacterium minutissimum Blood
Corynebacterium striatum Blood
Corynebacterium urealyticum Blood
Enterobacter cloacae Urine
Enterobacter aerogene Urine
Enterococcus casseliflavus Blood
Enterococcus faecalis Bacso/atcc 29212
Enterococcus faecium Blood
Enterococcus gallina rum Blood
Escherichia coli Bacso/atcc 25922
Haemophilus influenzae Bacso/atcc 49247
Haemophilus influenzae Bacso/atcc 49766
Hafnia alvei Bile
Klebsiella oxytoca Blood
Klebsiella pneumoniae Urine
Morganella morganii Urine
Nocardia sp. Bronchial aspirate
Proteus mirabilis Urine
Proteus vulgaris Bronchial aspirate
Providencia stuartii Urine
Pseudomonas aeruginosa Bacso/atcc 27853
Pseudomonas luteola Bronchial aspirate
Salmonella sp. Group B Feces
Salmonella sp. Group C Feces
Salmonella sp. Group D Feces
Serratia marcescens Urine
Staphylococcus aureus Bacsoatcc 29213
Staphylococcus epidermidis Blood
Staphylococcus haemolyticus Blood
Staphylococcus hominis Blood
Staphylococcus warneri Blood
Stenotrophomonas maltophilia Faringeal swab
Streptococcus agalactiae Uretral swab
Streptococcus anginosus Blood
Streptococcus mitis Blood
Streptococcus parasanguinis Blood
Streptococcus pyogene Faringeal swab
Streptococcus pneumoniae Bacso/atcc 49619
the bacterial collection at the same Institution (BACSO).
A cell suspension containing 108 CFU/mL was obtained
from each bacterial isolate, and the DNA was extracted
using described protocols [22]. PCR products obtained from
bacterial cultures were then sequenced to verify whether just
bacterial DNA had been amplified and cloned. In addition,
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five eukaryotic species from the genus Candida (Candida
albicans, Candida glabrata, Candida tropicalis, Candida para-
psilosis, and Candida guilliermondii) were included in the
study.
2.4. PCR Sensitivity Test. An external standard for absolute
quantification (i.e., the target 23S rDNA gene fragment,
cloned into a plasmid vector) was prepared. PCRwas effected
on Staphylococcus aureus DNA using the above described
primers PAN23S-F and PAN23S-R according to standard
PCR conditions. The band resolved on a 2% agarose gel was
excised and the PCR product was then purified, quantified,
and cloned using the pGEM T-easy vector (Qiagen, Basel,
Switzerland) according to manufacturers’ instructions. Ten
randomly selected clones were sequenced with ABI technol-
ogy. A plasmid containing the 23S rDNA insert was purified
from one of the clones, using the QIAprep Spin Miniprep
Kit (Qiagen, Basel, Switzerland). After quantification, a serial
dilution of the plasmid was used to assess the sensitivity of
the above PCR assay, with plasmid at concentrations ranging
from 108 to 101 copies per reaction, to generate the standard
curve.
2.5. DNA Extraction from Whole Blood Spiked with Gram-
Positive and Gram-Negative Bacteria. Tenfold serial dilution
of bacteria in blood was prepared, by spiking fresh K
3
EDTA
blood samples with S. aureus ATCC 25923 or E. coli ATCC
25922 (as representative strains for Gram-positive andGram-
negative bacteria), to obtain final concentrations of bacteria
ranging from 107 CFU per mL to 10 CFU per mL of blood.
A written informed consent was obtained from each blood
donor following the ethical rules of the St. Orsola Hospital
Blood Bank in Bologna. As a control, identical series were
prepared in phosphate buffer saline (PBS). Standard 100 𝜇L
volumes from each sample of these spiked series (blood or
PBS) were subjected to DNA extraction, using the differ-
ent protocols reported below. Two different commercially
available methods were used following the manufacturers’
instructions: the automated nucleic acid extractor NucliSens
EasyMag (BioMerieux, Marcy l’Etoile, France) and the man-
ual QIAmpDNAbloodmini kit (Qiagen, Basel, Switzerland).
As a third option, the following modification of the QIAmp
DNA blood mini kit was also used: 100 𝜇L of fresh whole
blood or PBS spiked series were preincubated with 90 𝜇L of
the enzyme solution buffer (20mg/mL lysozyme, 20mMTris
HCl, 2mMEDTA, 1%Triton). After 2 h of incubation at 37∘C,
the mixture was incubated at 56∘C for 2 h with addition of
10 𝜇Lof proteinaseK, at a concentration of 20mg/mL (Sigma-
Aldrich, St. Louis, MO, USA) and 100 𝜇L of AL Buffer. Then,
themixture (of 300𝜇L)was subjected toDNAextractionwith
the QIAmp DNA blood mini kit. The DNA obtained using
the three different procedures was eluted to a final volume
of 50𝜇L. In summary, these 50𝜇L of eluted DNA derived
from 1/10 of the blood spiked with the above number of
CFUs (i.e., 106–100 CFU in each 50𝜇L elution). This implies
that the five microliters used as template DNA for real-time
PCR contained bacterial DNAs derived from 105−10−1 CFU.
A series of blood samples spiked as above with E. coli
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Figure 1: Analysis of PANB-forward and PANB-reverse primers
homology sequences against the 23S rDNA of the most common
pathogenic bacteria species, Homo sapiens, Caenorhabditis elegans,
Candida albicans and Drosophila melanogaster in their binding
areas.
or S. aureus were processed for plasma preparation: the
spiked series of blood samples were incubated for 2 hours
at room temperature (RT) and then centrifuged at 400 g
for 15 minutes at RT. DNA was then extracted as above,
using the three different procedures. Each extracted DNA
was tested by real-time PCR, and the CT values were applied
to the standard curve generated in the same experiment to
obtain the corresponding copy number of bacterial 23S rDNA
gene targets in each reaction. Additionally, real-time PCR
was performed on DNA extracted from blood from healthy
donors, used as negative control.
3. Results
3.1. Specificity and Sensitivity of the 23S Real-Time PCR Assay.
The comparison of the designed primers with the sequences
from the 50 bacterial species included in the alignment shows
an almost complete identity, with no mismatches at the 3󸀠
end, while a high number of mismatches are present in the
alignment with the eukaryotic organisms included, that is,H.
sapiens,C. elegans,C. albicans, andD.melanogaster, as shown
in Figure 1.
In order to validate our in silico findings, the speci-
ficity of the novel 23S rDNA-targeted primers was also
evaluated on a total of 20 Gram-positive and 27 Gram-
negative bacterial strains (see Table 1 for details) and on five
eukaryotic species, from the genus Candida (see Section 2).
PCR amplification was obtained from the 47 bacterial DNAs,
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Figure 2: Standard curve amplification of cloned bacterial 23S
rDNA plasmid real-time PCR ranging from 108 to 101 copies per
reaction. Panel (a) shows the amplification curve constructed by
PCR assay. The fluorescence and the corresponding cycle numbers
are shown in the vertical and horizontal axes, respectively. Panel (b)
shows the relative standard curve ranging from 101 to 108 copies per
reaction. Panel (c) shows the corresponding melting curve.
with all the melting curves displaying a sharp peak at the
expected Tm; no amplification was obtained from any of
the Candida-derived DNA (results not shown). Additionally,
PCR products obtained from each bacterial amplification
were cloned and sequenced as previously described. Sequence
of all PCR products obtained was identified as derived from
the expected 23S rDNA fragment; these results demonstrate
that the developed PCR method specifically detects all the
bacterial species tested.
PCR sensitivity was evaluated on a serial dilution of
the plasmid containing the 23S rDNA fragment (with each
dilution tested in triplicate), at concentrations ranging from
108 to 101 plasmid copies per reaction, to generate a standard
curve (R value: 0.97; slope value: −2,527; Figure 2). The
detection limit of this PCR assay (standard curve method)
was 10 copies of 23S rDNA copies/reaction. The melting
curve analysis of the 23S rDNA gene product is shown in
Figure 2(c). The electrophoresis run for the PCR products
showed a unique specific band of 97 pb corresponding to the
23S rDNA gene, thus indicating high specificity.These results
demonstrate that the developed PCR method can detect up
to 10 copies per reaction, as shown in Figure 2.
3.2. DNA Extraction from Whole Blood and PBS Spiked with
Gram-Positive and Gram-Negative Bacteria. We evaluated
the efficiency of the two commercially DNA extraction
methods in PBS and whole blood spiked with E. coli and S.
aureus. Each experiment included a nonspiked whole blood
sample as a negative control. In these negative specimens
we never observed a completely negative amplification, given
the presence of traces of environmental bacterial DNA.
Therefore, in order to set up and define the exact number
of 23S rDNA copies detected for each sample, the cycle
threshold value of the corresponding negative control was
used as the edge limit of detection for each run.
The examination of sensitivity for detection of E. coli in
PBS after EasyMag extraction showed a positive signal for
concentrations in each PCR reaction in the 10 to 102 CFU
range; when blood samples were examined, a 10-fold decrease
in the detection sensitivity was observed (Figure 3(a)). When
S. aureus was tested, the detection sensitivity decreased to
103 CFU per PCR in the case of PBS suspension and to
above 103 CFU per PCR when whole blood specimens were
evaluated, as shown in Figure 3(d).
The QIAmp DNA blood mini kit extraction method
showed a detection limit for E. coli of 1 CFU per PCR in PBS
and of 10 CFU per PCR in whole blood samples (Figure 3(b)).
The lowest detectable concentrations of S. aureus in PBS
and whole blood specimens were 102 and 103 CFU per PCR,
respectively (Figure 3(e)).
When the pre-treatment step with lysozime and
proteinase K was introduced in the QIAmp extraction
protocol the PCR sensitivity rose 10-fold for S. aureus
(Figure 3(f)) whereas no increase was demonstrated for E.
coli (Figure 3(d)). In particular, the detection limit for E.
coli was 1 and 10 CFU per PCR in PBS and in whole blood,
respectively. The detection limit for S. aureus 23S rDNA
ranged from 1 to 10 CFU per PCR and 10 to 102 CFU per
PCR, respectively, for the bacterial suspension in PBS and
whole blood. Similar results were shown for whole blood
samples by Zucol and coworkers by using a set of primers
and a specific probe targeted on the 16S RNA gene with an
extraction protocol based on enzymatic [6].
3.3. Comparison of the Bacterial 23S rDNA Copy Number in
Whole Blood and in Plasma. Given the potential application
of the novel broad-spectrum PCR assay either in plasma
or whole blood specimens, we quantified and compared
the detection limit of the novel PCR protocol in whole
blood specimens spiked with different bacteria and in the
derived corresponding plasma samples, as described above.
Our results showed that the EasyMag extraction protocol
presented a 100-fold reduction of detection sensitivity in
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Figure 3: Analytical sensitivities of three different extraction protocols following quantification by the novel 23S rDNA real-time PCR from
whole blood (continuous line) and PBS (dotted line) spiked with different Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus
aureus) bacteria ranging from 1 to 105 bacteria per reaction. EasyMag automated extraction protocols with E. coli (a) or with S. aureus (d)
spiked in PBS and in whole blood. QIAmp DNA blood mini kit extraction methods with E. coli (b) or with S. aureus (e) spiked in PBS and
in whole blood; QIAmp DNA blood mini kit extraction with pretreatment with lysozyme and proteinase K with E. coli (c) or with S. aureus
(f), spiked in PBS and in whole blood. Results are representative of three independent experiments, effected on three independent DNA
extractions and expressed as mean ± standard deviations.
the plasma in comparison to the corresponding WB samples
(Figures 4(a) and 4(d)). Similarly, the QIAmp DNA blood
mini kit with or without the enzymatic pre-treatment showed
a similar behavior (Figures 4(b), 4(c), 4(e), and 4(f)). In par-
ticular, the QIAmp DNA blood mini kit with pre-treatment
showed a positive signal for E. coli for as low as 101 and
103 CFU per PCR from whole blood and plasma, respectively
(Figure 4(c)), and the minimum detection limit for S. aureus
ranged from 101 to 102 CFU per PCR and 102 to 103CFU per
PCR from whole blood and plasma (Figure 4(f)). Our results
showed that the PCR sensitivity was lower in plasma samples
than in the corresponding whole blood samples for both S.
aureus and E. coli, independently from the extractionmethod
used.
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Figure 4: Analytical detection range and sensitivities of different extraction protocols fromwhole blood (continuous line) spiked with Gram-
negative (E. coli) or Gram-positive (S. aureus) bacteria and their corresponding plasma (dotted line). EasyMag protocols with E. coli (a) or
with S. aureus (d), spiked in plasma and in whole blood. QIAmp DNA blood mini kit extraction with E. coli (b) or with S. aureus (e), spiked
in plasma and in whole blood; QIAmp DNA blood mini kit extraction with pre-treatment with lysozime and proteinase K with E. coli (c) or
with S. aureus (f), in plasma and in whole blood.
4. Discussion
In this study, we developed and assessed the analytical
performance of a novel real-time PCR method targeted on
a conserved region of the 23S ribosomal DNA gene, for
the detection and quantification of a wide range of human
pathogenic bacteria in human blood and plasma samples.
PCR assays capable of detecting a wide range of human
pathogens are nowadays important tools in microbiology
laboratories, useful for the detection and identification of
infecting bacteria, in particular in the case of blood stream
infections. This approach demonstrated its utility in cases of
patients receiving ongoing antimicrobial therapy or infected
by fastidious/not cultivable bacteria [1, 9]. So far, 16S rDNA
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has been the most widely used target for these applications.
As detailed in the introduction, one concern that was raised
against 16S rDNA-based approaches was its possible lack
of specificity, for example, the cross-reactivity with human
DNA, but this issue was not largely investigated [18, 23–
25]. As target for a pan-bacterial PCR, the 23S rDNA region
offers some advantages compared to 16S rDNA: (i) a higher
content of variable sequence stretches, (ii) the presence of
unique insertions/deletions, and (iii) possibility of a better
phylogenetic resolution because of a higher sequence varia-
tion [19, 26, 27].
The novel 23S rDNA-targeted PCR assay described here
was able to specifically detect all of the 47 bacterial isolates
included in the study that represent an estimated 90% of
the reported causes of blood stream infections [6]; no false
positive reactions were observed when eukaryotic DNAs
of diverse origin were tested. A previous study conducted
by Zucol and co-workers showed a sensitivity lower than
that reported here, when combined nucleic acids extraction
methodswere applied towater bacterial suspensions and then
followed by a 16SrDNA-targeted broad-spectrum real-time
PCR assay [6]. As expected, the performance of that method
was lower when applied to detect Gram-positive in respect to
Gram-negative bacteria, likely due to the thicker cell wall of
the former [6].
The minimal detection limits determined for the novel
real-time PCR described here were in the range of 1 to
103 CFU per reaction in whole blood spiked with E. coli
or S. aureus, depending on DNA extraction methods; as
expected, this indicates that the DNA purification step can
have a profound effect on the final results. The modified
QIAmp DNA blood mini kit, with pre-treatment of the
samples with proteinase K and lysozyme that contribute
to the disruption of the bacterial cell envelopes, led to a
sensitivity of the overall procedure that appears superior
compared to methods without preenzymatic treatments (see
Figure 3).
Some previously published studies showed controversial
results for the detection of the bacterial 16S rDNA in blood.
In particular, differences were found when whole blood or
plasma specimens were evaluated [7, 15, 20, 28]. The effective
difference in the amount of bacterial rDNAs detectable in
whole blood or plasma samples remains up to today not fully
investigated, so that the discussion about the optimal type of
samples to be used for the detection of bacterial rDNAs from
blood stream specimens is still ongoing [2]. In this study, we
tested whole blood samples spiked with either E. coli or S.
aureus and the derived plasma specimens, demonstrating that
the detection of 23S rDNA was more effective when whole
blood was used.
These results suggest that for an appropriate and effective
detection of bacterial 23S rDNA the most promising type
of sample is whole blood, while plasma must be considered
a second choice, given the lower detection limit. A major
weakness of the novel test described in this paper is the
short sequence, 97 base pair, used as target for the assay, that
makes quite unlikely the possibility to use the amplicons for a
successive species identification, based on sequence analysis.
On the other hand, it should be considered that in most
cases of invasive bacterial disease and in particular in blood
stream infections, the bacterial load in biological samples,
such as cerebrospinal fluid and blood, is usually quite low
and the use of a very sensitive diagnostic method, like the
novel PCR assay described in this paper, is highly desirable in
order to prove the microbial etiology. A similar approach was
recently described by Banada and co-workers, who showed
that an increase in the sensitivity of the PCR protocol can
be obtained by a decrease in amplicon size [28]. Additional
methods, capable of identifying the infective germs could be
applied later on in the diagnostic workflow, eventually with
additional steps capable of increasing the bacterial load, such
as enrichment broth culture or testing on specimens obtained
after withdrawal or suspension of the antimicrobial therapy.
The presence of bacterial products, including nucleic acids,
in the blood is nowadays a well-recognized phenomenon
that frequently occurs when pathological conditions allow
translocation from highly colonized sites, such as the bowel
[29, 30]. One major application of the method in this study
could be the quantification of total bacterial DNA in the
bloodstream in all the cases in which a sensitive detection
of DNA is desired without the need for a precise bacterial
species identification.
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